Clinical Trials Browser

Terminated × MSI-H Colorectal Cancer × pembrolizumab × Clear all

NCT06006923 2026-01-20

Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

Phase 2 Terminated

GastrointestinalOther solid neoplasm

MSI-H Colorectal Cancer